We examined whether the formation or the release of the vasodilators adenosine, prostacyclin (PGI2) and potassium (K+) increase in skeletal muscle interstitium in response to nitric oxide synthase (NOS) inhibition. Five subjects performed one-legged knee extensor exercise at 30 W without (controls) and with prior NG-nitro-L-arginine methyl ester (L-NAME) infusion (4 mg/kg, intravenously). Samples from the interstitial fluid were obtained at rest, during exercise and after exercise with the microdialysis technique. Interstitial adenosine in controls increased (p < 0.05) from 0.11 ± 0.03 μmol/l at rest to 0.48 ± 0.06 μmol/l during exercise. Interstitial adenosine during exercise in L-NAME was similar (p > 0.05) to controls. The 6-keto-prostaglandin F1α concentration in controls was 1.17 ± 0.20 ng/ml at rest and increased (p < 0.05) to 1.97 ± 0.30 ng/ml during exercise and was further elevated (p < 0.05) to 2.76 ± 0.38 ng/ml after exercise and these concentrations were not different (p > 0.05) in L-NAME. The interstitial K+ concentration in controls increased (p < 0.05) from 4.1 ± 0.1 mmol/l at rest to 9.5 ± 0.5 mmol/l during exercise. The interstitial K+ concentration during exercise (6.7 ± 0.4 mmol/l) was lower (p < 0.05) in L-NAME than in controls. The present findings demonstrate that the muscle interstitial concentrations of adenosine, PGI2 and K+ during exercise are not increased with systemic NOS inhibition. Thus, the lack of effect of NOS inhibition on the rate of blood flow to contracting human skeletal muscle does not appear to be due to compensatory formation or release of adenosine, PGI2 and K+ in the muscle interstitium. The present study also supports a role for PGI2 in the regulation of blood flow during exercise.

Keywords:
Blood flow regulation, Exercise, Nitric oxide, Prostaglandin, Skeletal muscle
1.
Wilson JR, Kapoor S: Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J Appl Physiol 1993;79:2740–2744.
2.
Brett SE, Cockcroft JR, Mant TGK, Ritter JM, Chowienczyk PJ: Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise. J Hypertens 1998;16:29–435.
3.
Koller SJ, Eichler HG, Wolzt M, Muller M, Entlicher J, Eichler HG, Schmetterer L: Role of nitric oxide in exercise induced vasodilation in man. Life Sci 1998;61:1035–1042.
4.
Rådegran G, Saltin B: Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol 1999;276:H1951–H1960.
5.
Gilligan DM, Panza JA, Crescence MA, Waclawiw MA, Casino PR, Quyyumi AA: Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994;90:2853–2858.
6.
Nakane M, Schmidt HHHW, Pollock JS, Förstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316:175–180.
7.
Frandsen U, Lopez-Figueroa M, Hellsten Y: Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 1996;227:88–93.
8.
Roberts CK, Barnard J, Jasman A, Balon TW: Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol 1999;277:E390–E394.
9.
Balon TW, Nadler JL: Nitric oxide release is present from incubated skeletal muscle preparations. J Physiol (Lond) 1994;77:2519–2521.
10.
Frandsen U, Bangsbo J, Nielsen JJ, Hellsten Y: Adenosine, potassium, NO2 and NO3 concentrations in the interstitial fluid of resting and contracting human skeletal muscle: Effects of AMP and norepinephrine infusion. Physiologist 1998;41/4:267.
11.
Dobson JG, Rubio R, Berne M: Role of adenine nucleotides, adenosine and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res 1971;29:375–384.
12.
Rådegran G: Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 1997;83:1383–1388.
13.
Hellsten Y, Maclean D, Rådegran G, Saltin B, Bangsbo J: Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation 1998;98/1:6–8.
14.
Bunting S, Gryglewski R, Moncada S, Vane JR: Arterial walls generate from prostagladin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976;12:565–574.
15.
Duffy SJ, New G, Tran BT, Harper RW, Meredith IT: Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999;276:H663–H670.
16.
Dusting GJ, Moncada S, Vane JR: Vascular actions of archidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Eur J Pharmacol 1978;49:65–72.
17.
Smith EF, Ogletree ML, Sherwin JR, Lefer AM: Effects of prostagladins on distribution of blood flow in the cat. Prostaglandins Med 1978;1:411–418.
18.
Wilson JR, Kapoor SC, Krishna GG: Contribution of potassium to exercise-induced vasodilation in humans. J Physiol 1994;77:2552–2557.
19.
Juel C, Pilegaard H, Nielsen JJ, Bangsbo J: Interstitial K+ in human skeletal muscle during and after dynamic graded exercise determined by microdialysis. Am J Physiol 2000;278:R400–R406.
20.
Tayama S, Okumura T, Matsunaga T, Tsunoda R, Tabuchi, T, Iwasa, A, Yasue H: Influence of chronic nitric oxide inhibition of coronary blood flow regulation. Jpn Circ J 1998;62:371–378.
21.
Tomohiro O, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, Okumura K: Cross-talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol 2000;278:H233–H238.
22.
Puybasset L, Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A: Coronary and systemic haemodynamic effecs of sustained inhibition of nitric oxide synthesis in concious dogs: Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res 1996;79:343–357.
23.
Andersen P, Adams RP, Sjøgaard G, Thorboe A, Saltin B: Dynamic knee extension as a model for the study of an isolated exercising muscle in man. J Appl Physiol 1985;59:1647–1653.
24.
Rådegran G, Pilegaard H, Nielsen JJ, Bangsbo J: Microdialysis ethanol removal reflects probe recovery rather than local blood flow in skeletal muscle. J Appl Physiol 1998;85:751–757.
25.
Nitsch J, Steinbeck G, Luderitz B: Comparison of myocardial potassium and thallium flux as studied by tracer methods. Clin Cardiol 1980;3:188–191.
26.
Scheller D, Kolb J: The internal reference technique in microdialysis: A practical approach to monotoring dialysis effiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 1991;40:31–38.
27.
Andersen P, Saltin B: Maximal perfusion of skeletal muscle in man. J Physiol (Lond) 1985;366:233–249.
28.
Tullson P, Bangsbo J, Hellsten Y, Richter E: IMP metabolism in human skeletal muscle following exhaustive exercise. J Appl Physiol 1995;78:146–152.
29.
Shoemaker JK, Halliwell JR, Hughson RL, Joyner MJ: Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol 1997;273:H2388–H2395.
30.
McCulloch AI, Bottrill FE, Randall MD, Hiley CR: Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 1997;120:1431–1438.
31.
Félétou M, Vanhoutte PM: Endothelian dysfunction: A novel therapeutic target. The alternative: EDRF. J Moll Cell Cardiol 1999;31:15–22.
32.
Salmon JA, Smith DR, Flower RJ, Moncada S, Vane JR: Further studies on the enzymatic conversion of prostaglandins endoperoxide into prostacyclin by porchine aorta microsomes. Biochim Biophys Acta 1978;523:250–262.
33.
Steinberg H, Mevedev OS, Luft FC, Unger T: Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat. J Cardiovasc Pharmacol 1988;11:84–89.
34.
Bangsbo J, Hellsten Y: Muscle blood flow and oxygen uptake in recovery from exercise. Acta Physiol Scand 1998;162:305–312.
35.
Langberg H, Skovgaard D, Karamouzis M, Bülow J, Kjær M: Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol 1999;515:919–927.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.